Whole body vibration to preserve physical functioning in patients with hematological malignancies under chemotherapy
Not Applicable
- Conditions
- hematologic malagnancies
- Registration Number
- DRKS00004338
- Lead Sponsor
- niversitätsklinik Freiburg,Klinik für Innere Medizin ISchwerpunkt Hämatologie, Onkologie und Stammzelltransplantation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
patients with hematological malignancies and an planned stationary stay of at least two weeks because of chemotherapy, signed informed consent.
Exclusion Criteria
Endoprosthesis in knee oder hip, other meta implant in lower extremities, fractures, acute arthritis, venous thrombosis, epilepsy, instable bone metastases, unknown back pain, acute slipped disc, myocardial infarction, Angina pectoris or heart disease (NYHA III-IV) in a time period of 6 months, arterial hypertension, cardial pacemaker, which is not treated adequately (in therapy >180mmHg systolic; >100mmHg diastolic),
Thrombocytes = 10.000µl, hemoglobin < 8g/dl
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Performed exercise sessions in relation to planned exercise sessions of intervention group compared to control group [%], feasibility studxy
- Secondary Outcome Measures
Name Time Method 1. self created questionnaire about vibration tolerance [score]<br>2. Force plate (GKS 1000, Mittweida) [cm]<br>(sway path of center of pressure [COP]) and timed-up-and-go-test [sec] (postural control and mobility)<br>3. EORTC QLQ-C30 (quality of life questionnaire)